| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Therapy | 28 | 2014 | 1616 | 4.600 |
Why?
|
| Interleukin-12 | 20 | 2014 | 253 | 4.550 |
Why?
|
| Electroporation | 20 | 2014 | 126 | 4.500 |
Why?
|
| Electrochemotherapy | 7 | 2010 | 9 | 2.100 |
Why?
|
| Gene Transfer Techniques | 10 | 2014 | 716 | 2.010 |
Why?
|
| Vimentin | 5 | 2014 | 253 | 1.830 |
Why?
|
| Interleukins | 5 | 2014 | 325 | 1.520 |
Why?
|
| Plasmids | 15 | 2014 | 837 | 1.330 |
Why?
|
| Neoplasms, Experimental | 7 | 2014 | 750 | 1.280 |
Why?
|
| Mice, Inbred C3H | 15 | 2013 | 385 | 1.140 |
Why?
|
| Carcinoma, Squamous Cell | 13 | 2014 | 5437 | 1.050 |
Why?
|
| Bleomycin | 4 | 2010 | 467 | 1.010 |
Why?
|
| Dog Diseases | 3 | 2010 | 73 | 1.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 2 | 2014 | 56 | 0.980 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2014 | 973 | 0.940 |
Why?
|
| Peptides | 5 | 2014 | 1479 | 0.880 |
Why?
|
| Receptors, Cytokine | 4 | 2012 | 176 | 0.840 |
Why?
|
| Mice, Inbred BALB C | 14 | 2015 | 2314 | 0.830 |
Why?
|
| Interferon-gamma | 8 | 2012 | 1144 | 0.760 |
Why?
|
| Animals | 58 | 2015 | 59536 | 0.730 |
Why?
|
| STAT1 Transcription Factor | 4 | 2012 | 156 | 0.700 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2014 | 607 | 0.700 |
Why?
|
| Cell- and Tissue-Based Therapy | 2 | 2014 | 406 | 0.700 |
Why?
|
| Mice | 45 | 2015 | 34495 | 0.690 |
Why?
|
| Cytokines | 6 | 2013 | 2809 | 0.680 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2013 | 1033 | 0.660 |
Why?
|
| Genes, Reporter | 6 | 2012 | 798 | 0.620 |
Why?
|
| Neoplasms | 10 | 2014 | 15193 | 0.620 |
Why?
|
| DNA, Recombinant | 5 | 2008 | 121 | 0.620 |
Why?
|
| Biomarkers, Tumor | 5 | 2015 | 10331 | 0.590 |
Why?
|
| DNA | 6 | 2013 | 2693 | 0.580 |
Why?
|
| Cell Line, Tumor | 21 | 2015 | 14551 | 0.580 |
Why?
|
| Drug Delivery Systems | 3 | 2011 | 669 | 0.570 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2014 | 1586 | 0.550 |
Why?
|
| Receptors, Interleukin | 3 | 2012 | 97 | 0.540 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2004 | 650 | 0.530 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2014 | 22 | 0.510 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2014 | 33 | 0.510 |
Why?
|
| Hepatic Stellate Cells | 1 | 2014 | 30 | 0.510 |
Why?
|
| Fibrinogen | 1 | 2015 | 205 | 0.480 |
Why?
|
| Electricity | 1 | 2014 | 17 | 0.480 |
Why?
|
| Interleukin-17 | 3 | 2011 | 250 | 0.480 |
Why?
|
| Interleukin-10 | 2 | 2013 | 478 | 0.480 |
Why?
|
| Maxillary Neoplasms | 1 | 2014 | 23 | 0.480 |
Why?
|
| Macrophages, Peritoneal | 1 | 2013 | 66 | 0.470 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2015 | 8873 | 0.460 |
Why?
|
| CD40 Ligand | 1 | 2013 | 115 | 0.460 |
Why?
|
| CD40 Antigens | 1 | 2013 | 104 | 0.450 |
Why?
|
| Natural Killer T-Cells | 1 | 2014 | 124 | 0.450 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 2 | 2002 | 6 | 0.440 |
Why?
|
| Dogs | 7 | 2014 | 1155 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 10 | 2015 | 6942 | 0.430 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 354 | 0.420 |
Why?
|
| Tumor Cells, Cultured | 8 | 2014 | 5395 | 0.420 |
Why?
|
| Ethyldimethylaminopropyl Carbodiimide | 1 | 2011 | 6 | 0.410 |
Why?
|
| Killer Cells, Natural | 4 | 2011 | 904 | 0.410 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2011 | 35 | 0.390 |
Why?
|
| CD3 Complex | 1 | 2012 | 314 | 0.390 |
Why?
|
| Glycoproteins | 1 | 2014 | 747 | 0.390 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 673 | 0.380 |
Why?
|
| Oncogenes | 1 | 2014 | 673 | 0.380 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 494 | 0.380 |
Why?
|
| Interferon-alpha | 2 | 2008 | 889 | 0.380 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2012 | 193 | 0.370 |
Why?
|
| Colonic Neoplasms | 3 | 2014 | 1390 | 0.370 |
Why?
|
| Transfection | 7 | 2014 | 2944 | 0.360 |
Why?
|
| Necrosis | 1 | 2011 | 580 | 0.360 |
Why?
|
| Antigens, CD | 1 | 2014 | 1385 | 0.350 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 803 | 0.350 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 1443 | 0.340 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 207 | 0.340 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 600 | 0.330 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 992 | 0.330 |
Why?
|
| Signal Transduction | 10 | 2014 | 11965 | 0.330 |
Why?
|
| Gene Expression Regulation | 6 | 2012 | 4053 | 0.320 |
Why?
|
| Flow Cytometry | 6 | 2014 | 3033 | 0.320 |
Why?
|
| STAT3 Transcription Factor | 2 | 2013 | 1121 | 0.310 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 941 | 0.310 |
Why?
|
| Up-Regulation | 7 | 2013 | 2450 | 0.300 |
Why?
|
| Transcription, Genetic | 6 | 2005 | 3154 | 0.300 |
Why?
|
| Muscle, Skeletal | 4 | 2008 | 1270 | 0.300 |
Why?
|
| NF-kappa B | 1 | 2013 | 1549 | 0.290 |
Why?
|
| B7-1 Antigen | 1 | 2006 | 88 | 0.290 |
Why?
|
| Head and Neck Neoplasms | 4 | 2009 | 3976 | 0.280 |
Why?
|
| Immunologic Memory | 2 | 2013 | 374 | 0.280 |
Why?
|
| Disease Models, Animal | 4 | 2013 | 7222 | 0.270 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 3230 | 0.270 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 1823 | 0.270 |
Why?
|
| Endolymphatic Sac | 2 | 2002 | 11 | 0.270 |
Why?
|
| Macrophages | 1 | 2012 | 1304 | 0.270 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 1555 | 0.260 |
Why?
|
| Precision Medicine | 1 | 2013 | 1154 | 0.260 |
Why?
|
| Mice, SCID | 3 | 2015 | 1869 | 0.260 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2005 | 87 | 0.260 |
Why?
|
| Luciferases | 4 | 2012 | 445 | 0.260 |
Why?
|
| Doxorubicin | 2 | 2014 | 3005 | 0.250 |
Why?
|
| Bone Marrow | 1 | 2012 | 2358 | 0.250 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2004 | 11 | 0.250 |
Why?
|
| Neoplasm Metastasis | 2 | 2012 | 5112 | 0.240 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2008 | 588 | 0.240 |
Why?
|
| Genetic Vectors | 3 | 2005 | 1694 | 0.240 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2008 | 726 | 0.240 |
Why?
|
| Glioblastoma | 1 | 2015 | 1797 | 0.240 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2002 | 173 | 0.240 |
Why?
|
| Inflammation | 1 | 2014 | 2522 | 0.240 |
Why?
|
| Gene Expression | 8 | 2009 | 3570 | 0.240 |
Why?
|
| Digestive System | 1 | 2004 | 114 | 0.240 |
Why?
|
| Recombinant Proteins | 5 | 2008 | 2927 | 0.230 |
Why?
|
| DNA-Binding Proteins | 5 | 2005 | 4821 | 0.230 |
Why?
|
| Interferons | 1 | 2005 | 291 | 0.230 |
Why?
|
| Sarcoma | 1 | 2014 | 1725 | 0.230 |
Why?
|
| Respiratory System | 1 | 2004 | 125 | 0.230 |
Why?
|
| src-Family Kinases | 2 | 1996 | 478 | 0.220 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2002 | 68 | 0.220 |
Why?
|
| Chemokine CXCL9 | 4 | 2004 | 22 | 0.220 |
Why?
|
| Radiation Tolerance | 2 | 2008 | 629 | 0.220 |
Why?
|
| Ear, Inner | 1 | 2002 | 57 | 0.220 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 905 | 0.220 |
Why?
|
| Liposomes | 1 | 2004 | 684 | 0.210 |
Why?
|
| Mice, Knockout | 4 | 2014 | 5710 | 0.210 |
Why?
|
| Chemokines, CXC | 4 | 2004 | 117 | 0.210 |
Why?
|
| Guanylate Cyclase | 1 | 2002 | 74 | 0.210 |
Why?
|
| HeLa Cells | 7 | 2011 | 1643 | 0.210 |
Why?
|
| Combined Modality Therapy | 5 | 2014 | 8865 | 0.200 |
Why?
|
| Humans | 35 | 2015 | 261506 | 0.200 |
Why?
|
| Blotting, Western | 4 | 2014 | 3536 | 0.190 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2001 | 110 | 0.190 |
Why?
|
| Muscles | 1 | 2002 | 416 | 0.190 |
Why?
|
| Single-Cell Analysis | 2 | 2014 | 470 | 0.190 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 663 | 0.190 |
Why?
|
| Interleukin-2 | 2 | 2001 | 842 | 0.190 |
Why?
|
| Cyclophosphamide | 1 | 2008 | 3001 | 0.190 |
Why?
|
| Protein Biosynthesis | 5 | 2002 | 889 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 3251 | 0.180 |
Why?
|
| RNA, Messenger | 8 | 2015 | 6150 | 0.180 |
Why?
|
| Models, Genetic | 2 | 2009 | 1113 | 0.180 |
Why?
|
| Cell Communication | 2 | 2013 | 509 | 0.180 |
Why?
|
| Interferon Regulatory Factor-7 | 3 | 2005 | 26 | 0.180 |
Why?
|
| Codon | 2 | 1997 | 241 | 0.180 |
Why?
|
| Female | 21 | 2015 | 141928 | 0.180 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2002 | 467 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1997 | 611 | 0.170 |
Why?
|
| Analysis of Variance | 3 | 2015 | 2307 | 0.170 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2012 | 78 | 0.170 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2013 | 1016 | 0.160 |
Why?
|
| Terminator Regions, Genetic | 2 | 1997 | 8 | 0.160 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 15862 | 0.160 |
Why?
|
| Base Sequence | 6 | 2014 | 4917 | 0.160 |
Why?
|
| Dendritic Cells | 1 | 2004 | 1085 | 0.160 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 4849 | 0.160 |
Why?
|
| Immunologic Surveillance | 1 | 1998 | 60 | 0.160 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1997 | 68 | 0.160 |
Why?
|
| Antibodies | 2 | 2014 | 838 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 3 | 2014 | 4367 | 0.150 |
Why?
|
| Trans-Activators | 2 | 2004 | 1555 | 0.150 |
Why?
|
| Codon, Nonsense | 4 | 2002 | 164 | 0.140 |
Why?
|
| Actins | 1 | 1999 | 608 | 0.140 |
Why?
|
| Butyrates | 1 | 1996 | 57 | 0.140 |
Why?
|
| Injections, Intramuscular | 3 | 2001 | 255 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 4971 | 0.130 |
Why?
|
| Cell Survival | 4 | 2013 | 3045 | 0.130 |
Why?
|
| Carbon Tetrachloride | 1 | 2014 | 24 | 0.130 |
Why?
|
| Cell Line | 4 | 2014 | 5114 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 1999 | 3101 | 0.130 |
Why?
|
| AC133 Antigen | 1 | 2014 | 110 | 0.130 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 107 | 0.120 |
Why?
|
| Buffers | 1 | 2014 | 44 | 0.120 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 123 | 0.120 |
Why?
|
| Permeability | 1 | 2014 | 167 | 0.120 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2014 | 189 | 0.120 |
Why?
|
| Blotting, Northern | 3 | 2004 | 682 | 0.120 |
Why?
|
| Melanoma | 1 | 2011 | 5317 | 0.120 |
Why?
|
| Erythrocyte Membrane | 1 | 2013 | 36 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2002 | 1620 | 0.120 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 164 | 0.110 |
Why?
|
| Antineoplastic Agents | 5 | 2011 | 14289 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 3639 | 0.110 |
Why?
|
| Drug Administration Routes | 1 | 2012 | 60 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 503 | 0.110 |
Why?
|
| Lymphocytes | 1 | 1998 | 1234 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2011 | 4307 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2012 | 261 | 0.110 |
Why?
|
| Interleukin-15 | 1 | 2013 | 185 | 0.110 |
Why?
|
| Culture Media | 1 | 2013 | 319 | 0.110 |
Why?
|
| Apoptosis | 4 | 2013 | 7591 | 0.110 |
Why?
|
| Concanavalin A | 1 | 2012 | 67 | 0.110 |
Why?
|
| Polymers | 1 | 2014 | 223 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2004 | 2508 | 0.100 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2012 | 110 | 0.100 |
Why?
|
| Protein Transport | 1 | 2014 | 734 | 0.100 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2011 | 39 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2014 | 558 | 0.100 |
Why?
|
| Ultrasonics | 1 | 2011 | 69 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 1062 | 0.100 |
Why?
|
| CpG Islands | 1 | 2013 | 633 | 0.100 |
Why?
|
| Chemokine CXCL10 | 2 | 2002 | 105 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 3203 | 0.100 |
Why?
|
| CD28 Antigens | 1 | 2012 | 202 | 0.100 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 122 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2015 | 649 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2014 | 850 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2015 | 9180 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2011 | 3869 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 769 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2014 | 2027 | 0.100 |
Why?
|
| Toxicity Tests | 1 | 2011 | 50 | 0.100 |
Why?
|
| Gene Amplification | 1 | 2014 | 731 | 0.100 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 11538 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 155 | 0.100 |
Why?
|
| Reading Frames | 2 | 2002 | 6 | 0.100 |
Why?
|
| ErbB Receptors | 2 | 2013 | 2295 | 0.100 |
Why?
|
| Mice, Inbred Strains | 2 | 2002 | 521 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 2232 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 598 | 0.090 |
Why?
|
| Cats | 1 | 2010 | 166 | 0.090 |
Why?
|
| Injections, Intralesional | 1 | 2010 | 164 | 0.090 |
Why?
|
| Haplorhini | 1 | 2009 | 130 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2011 | 626 | 0.090 |
Why?
|
| Gene Fusion | 1 | 2011 | 209 | 0.090 |
Why?
|
| Lipids | 1 | 2013 | 644 | 0.090 |
Why?
|
| Immune System | 1 | 2011 | 279 | 0.090 |
Why?
|
| Philadelphia Chromosome | 1 | 2013 | 793 | 0.090 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 1618 | 0.090 |
Why?
|
| Organ Size | 1 | 2011 | 690 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2011 | 403 | 0.080 |
Why?
|
| Trastuzumab | 1 | 2011 | 696 | 0.080 |
Why?
|
| Vaccines, DNA | 1 | 2009 | 105 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2013 | 554 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 702 | 0.080 |
Why?
|
| CD13 Antigens | 1 | 2008 | 36 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 3343 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 1081 | 0.080 |
Why?
|
| Protein Binding | 1 | 2014 | 3438 | 0.080 |
Why?
|
| Rabbits | 1 | 2009 | 957 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 2283 | 0.080 |
Why?
|
| Cattle | 1 | 2009 | 783 | 0.080 |
Why?
|
| Male | 8 | 2015 | 123000 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 541 | 0.080 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 1294 | 0.080 |
Why?
|
| Pyridines | 1 | 2014 | 1244 | 0.080 |
Why?
|
| Time Factors | 4 | 2002 | 12926 | 0.070 |
Why?
|
| Homeostasis | 2 | 2002 | 950 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2012 | 686 | 0.070 |
Why?
|
| Models, Animal | 1 | 2009 | 664 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 2 | 2014 | 2330 | 0.070 |
Why?
|
| Liver Neoplasms | 2 | 2014 | 4557 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1489 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 1130 | 0.070 |
Why?
|
| Tumor Necrosis Factors | 1 | 2006 | 34 | 0.070 |
Why?
|
| Alternative Splicing | 2 | 2002 | 584 | 0.070 |
Why?
|
| Disease Progression | 2 | 2014 | 6682 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1506 | 0.070 |
Why?
|
| Prognosis | 2 | 2014 | 21713 | 0.070 |
Why?
|
| DNA Primers | 2 | 2006 | 1399 | 0.070 |
Why?
|
| Papillomaviridae | 1 | 2009 | 624 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2006 | 150 | 0.070 |
Why?
|
| Colon | 1 | 2009 | 670 | 0.070 |
Why?
|
| Liver | 2 | 2012 | 2961 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 6089 | 0.060 |
Why?
|
| Swine | 1 | 2009 | 1541 | 0.060 |
Why?
|
| RNA Precursors | 3 | 2001 | 137 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2359 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2013 | 7226 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 2 | 2002 | 1547 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2008 | 1090 | 0.060 |
Why?
|
| Placebos | 1 | 2005 | 437 | 0.060 |
Why?
|
| Tumor Burden | 1 | 2010 | 1987 | 0.060 |
Why?
|
| Leukemia | 1 | 2012 | 1635 | 0.060 |
Why?
|
| Hypopharyngeal Neoplasms | 1 | 2004 | 82 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2006 | 1073 | 0.060 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2006 | 675 | 0.060 |
Why?
|
| Models, Biological | 2 | 2011 | 3254 | 0.060 |
Why?
|
| Meniere Disease | 1 | 2002 | 3 | 0.060 |
Why?
|
| Densitometry | 1 | 2002 | 45 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2002 | 60 | 0.060 |
Why?
|
| Rats, Inbred Lew | 1 | 2002 | 113 | 0.060 |
Why?
|
| Carbodiimides | 1 | 2002 | 7 | 0.060 |
Why?
|
| Down-Regulation | 3 | 1997 | 2074 | 0.050 |
Why?
|
| Glycerol | 1 | 2002 | 99 | 0.050 |
Why?
|
| Glycosaminoglycans | 1 | 2002 | 61 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2011 | 2022 | 0.050 |
Why?
|
| Connexin 26 | 1 | 2002 | 21 | 0.050 |
Why?
|
| Chemokine CCL7 | 1 | 2002 | 12 | 0.050 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2002 | 17 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 869 | 0.050 |
Why?
|
| Granzymes | 1 | 2002 | 91 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 212 | 0.050 |
Why?
|
| Connexins | 1 | 2002 | 78 | 0.050 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 2001 | 5 | 0.050 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2001 | 10 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 4233 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 197 | 0.050 |
Why?
|
| Receptor, ErbB-2 | 1 | 2011 | 2518 | 0.050 |
Why?
|
| Lymphokines | 1 | 2002 | 272 | 0.050 |
Why?
|
| Genes, Immunoglobulin | 1 | 2001 | 87 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 3552 | 0.050 |
Why?
|
| Codon, Terminator | 2 | 1998 | 42 | 0.050 |
Why?
|
| Osteosarcoma | 1 | 2008 | 929 | 0.050 |
Why?
|
| Cell Division | 2 | 2002 | 2489 | 0.050 |
Why?
|
| Hindlimb | 1 | 2001 | 105 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 862 | 0.050 |
Why?
|
| Aged | 3 | 2015 | 70117 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2002 | 275 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 1070 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2014 | 3341 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 703 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 1688 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 2004 | 518 | 0.050 |
Why?
|
| Adult | 3 | 2015 | 77950 | 0.050 |
Why?
|
| Exons | 3 | 2002 | 1328 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 1999 | 51 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 2796 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 771 | 0.040 |
Why?
|
| Middle Aged | 3 | 2015 | 86204 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 2005 | 697 | 0.040 |
Why?
|
| RNA Splicing | 2 | 2001 | 370 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2001 | 1053 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1996 | 1756 | 0.040 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1998 | 67 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 1999 | 288 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 4757 | 0.040 |
Why?
|
| RNA | 1 | 2002 | 1013 | 0.040 |
Why?
|
| Butyric Acid | 1 | 1996 | 13 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 1999 | 482 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1996 | 249 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1996 | 201 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 1996 | 147 | 0.030 |
Why?
|
| Rats | 2 | 2002 | 6086 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1995 | 71 | 0.030 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1995 | 36 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 1995 | 70 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2002 | 1533 | 0.030 |
Why?
|
| Binding Sites, Antibody | 1 | 1995 | 135 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1995 | 300 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1998 | 613 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2002 | 2803 | 0.030 |
Why?
|
| Mammals | 1 | 1997 | 361 | 0.030 |
Why?
|
| Catalysis | 1 | 1995 | 250 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1995 | 334 | 0.030 |
Why?
|
| Cisplatin | 1 | 2002 | 2432 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 5767 | 0.030 |
Why?
|
| Transcription Factors | 2 | 1999 | 5270 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 7789 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 52 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 15694 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 24 | 0.030 |
Why?
|
| Introns | 3 | 2002 | 432 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2013 | 49 | 0.030 |
Why?
|
| Aptamers, Nucleotide | 1 | 2013 | 62 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 60 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2013 | 125 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2013 | 471 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 4892 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 5159 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 7551 | 0.030 |
Why?
|
| Luminescence | 1 | 2011 | 44 | 0.030 |
Why?
|
| Testosterone | 1 | 1996 | 619 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 7548 | 0.020 |
Why?
|
| Folic Acid | 1 | 2013 | 349 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1996 | 1143 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 1764 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 615 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1995 | 1146 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 1008 | 0.020 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2013 | 1094 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2013 | 1152 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1217 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 984 | 0.020 |
Why?
|
| Survival Rate | 1 | 2001 | 12221 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 726 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 2488 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 1996 | 4078 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 2466 | 0.010 |
Why?
|
| Syndecans | 1 | 2002 | 27 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 2002 | 21 | 0.010 |
Why?
|
| Syndecan-1 | 1 | 2002 | 52 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2013 | 2819 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 355 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 311 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2002 | 220 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2002 | 259 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 706 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2002 | 566 | 0.010 |
Why?
|
| Heparin | 1 | 2002 | 360 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2002 | 1152 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 217 | 0.010 |
Why?
|
| Epididymis | 1 | 1996 | 68 | 0.010 |
Why?
|
| Gene Library | 1 | 1996 | 294 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 699 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 21445 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1996 | 652 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1995 | 294 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2002 | 3821 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 29902 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 31252 | 0.010 |
Why?
|
| Ovary | 1 | 1996 | 668 | 0.010 |
Why?
|
| Placenta | 1 | 1996 | 516 | 0.010 |
Why?
|
| Testis | 1 | 1996 | 717 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2002 | 2138 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 15179 | 0.010 |
Why?
|
| Pregnancy | 1 | 1996 | 7573 | 0.000 |
Why?
|